GO
Loading...

Enter multiple symbols separated by commas

Stocks Covidien Public Limited Company

More

  • One ethical fund's Four Commandments Tuesday, 12 Nov 2013 | 6:00 AM ET

    Doing well by doing good is an elusive goal, but George Schwartz seems to have figured out how to do well by not doing things he believes are bad.

  • Weak jobs report expected, but what if it's not? Thursday, 7 Nov 2013 | 7:11 PM ET
    People looking for work stand in line to apply for a job during a job fair in Miami on May 2.

    October's jobs report is expected to be one of the weakest of the year, distorted by the impact of the 16-day government shutdown.

  • IRS Disallows $2.86 Billion in Tyco Tax Deductions Tuesday, 2 Jul 2013 | 8:05 AM ET
    Tyco International Ltd. signage is displayed outside of the company's offices in Boca Raton, Florida, U.S.

    The IRS has informed Tyco that it has disallowed roughly $2.86 billion in interest and deductions recognized by the company in its U.S. returns for 1997-2000.

  • Early Movers: DIS, ZNGA, TYC, STZ, ONXX & More Tuesday, 2 Jul 2013 | 7:56 AM ET

    Some of the names on the move ahead of the open.

  • Covidien CEO on Pharma Spin-Off Monday, 1 Jul 2013 | 4:45 PM ET
    Covidien CEO on Pharma Spin-Off

    Covidien President & CEO Jose Almeida discusses why now is the best time to separate the pharma business. "Covidien has been growing above market," he says.

  • Cramer: This Break-Up Creating Immense Value Friday, 14 Jun 2013 | 6:15 PM ET

    Jim Cramer believes this company is about to create immense value with the stroke of a pen.

  • Cramer: Break-Up Could Boost This Stock 19% Friday, 17 May 2013 | 6:02 PM ET

    Cramer’s convinced the best way to for this health care company to maximize shareholder value is to break up.

  • Why S&P 1,500 May Signal Stock Rally Has Peaked Friday, 25 Jan 2013 | 12:26 PM ET

    The S&P 500 regained the 1,500 level for the first time in more than five years, but that's a milestone that could also trigger a pause, analysts say.

  • Bulls Gear Up for Another Run at 1,500 on S&P Thursday, 24 Jan 2013 | 9:35 PM ET

    Wall Street's bull could take another run at the psychologically important 1,500 level as early as Friday, but that's a level that could also trigger a pause, analysts say.

  • Will Tech Earnings Charge Up the Stock Market Rally? Friday, 18 Jan 2013 | 8:33 PM ET
    Google Maps app for Apple ios.

    A flood of earnings reports, including major technology and industrial companies, could make or break the stock market’s surprise January rally in the week ahead.

  • Ryan: Is the Health Care Sector 'Healthy?' Monday, 7 Jan 2013 | 2:13 PM ET

    CNBC Contributor Barbara Ryan is taking the pulse of health care stocks at this year's "Woodstock" of health care.

  • Stocks to Watch: P, FB, MFRM & More Wednesday, 5 Dec 2012 | 8:07 AM ET

    Here are Wednesday's morning movers.

  • Analyst downgrades Johnson & Johnson to "sell" Tuesday, 9 Oct 2012 | 12:00 AM ET

    NEW YORK-- Goldman Sachs downgraded Johnson& Johnson, saying Tuesday that the current share price has captured all the potential for improved growth. However, Goldman analyst Jami Rubin wrote that Johnson& Johnson comes up short in the two areas she sees as likely to boost stock prices, new prescription drugs and capital allocation.

  • *Announces FDA 510 clearance and ce mark for Nellcor (TM) bedside. *Says new system will be available in the United States and throughout the eea. in the next few months.

  • Covidien completes $100M CNS Therapeutics deal Tuesday, 2 Oct 2012 | 4:35 PM ET

    NEW YORK-- Drug and medical device maker Covidien PLC said Tuesday it completed its $100 million purchase of CNS Therapeutics. Covidien announced it was buying CNS on Sept. 24. CNS is now part of Covidien's Mallinckrodt pharmaceuticals business.

  • Corporate Splits, Just as Easy as TomKat Divorce Thursday, 12 Jul 2012 | 2:21 PM ET
    mm_avatar_100_cramer.jpg

    Jim Cramer’s researcher, Nicole Urken, takes a look at some pockets of value creation in this unpredictable market.

  • Covidien CEO Talks Acquisitions Monday, 9 Jul 2012 | 8:41 PM ET

    Joe Almeida, Covidien president & CEO, discussed his company's strategies for growth and much more.

  • Johnson & Johnson Remains Too Big to Succeed Thursday, 10 May 2012 | 12:28 PM ET
    Johnson & Johnson

    Few stock sectors are as reliable as drugs and health care, and astute investors know that companies such as Merck, Pfizer, and Abbott Laboratories have delivered healthy returns over the years. One stock that investors have become less enamored with, however, is Johnson & Johnson.

  • Your First Move For Tuesday February 28th Monday, 27 Feb 2012 | 7:06 PM ET

    Here's our Fast Money Final Trade. Our gang gives you tomorrow's best trades, right now!

  • 5 Deal-Ready Stocks Loved by Hedge Funds Thursday, 16 Feb 2012 | 3:52 PM ET

    Every quarter hedge funds and large investors file their holdings with the SEC, revealing value picks, cyclical bets, growth opportunities and activist pushes. TheStreet.com details five stocks that hedge funds flocked to.